New meta-analysis data suggest that temporary intragastric devices significantly improve liver morphology and biochemical ...

Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity ...

Ferrosa Therapeutics AG ("FERROSA"), a Swiss biotechnology company developing a first-in-class bispecific antibody to treat ...

Introduction Despite its serious impact, anorexia nervosa (AN) remains one of the least understood mental illnesses, with significant gaps in effective treatment options. No medications have been ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for cardiovascular disease ...

A new study published in Engineering reveals that obakulactone (OL), a natural tetracyclic triterpenoid isolated from ...

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and are now increasingly recognized as conditions with a strong ...

A common gut bacterium may be implicated in lupus kidney disease, and could potentially alter the diagnosis and treatment of ...

The last decade has witnessed significant developments in the understanding of the pathogenesis of alopecia areata, as well as the emergence of drugs which ...

Using single-nucleus RNA sequencing, the authors map transcriptional changes in the rat ventral tegmental area following chronic inflammatory pain and acute morphine exposure. Notably, their ...

Neuronal specification, expansion and differentiation are tightly regulated by the concerted actions of transcription and chromatin modifying factors that are recruited to regulatory elements in the ...

Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE)If app ...